SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Edward Paule who wrote (5351)1/16/1998 3:19:00 PM
From: aknahow  Respond to of 17367
 
While I think that with a great deal of work you could determine the hospitals involved and the deaths I doubt one could learn if those who died were in the trial. Remember they must be over the 8 poin in the scale used. So kids could die at a hospital involved in trials because they got to the hosp too late to be enrolled or were cured or died before gettin on the trial. Alsohe consent factor. How much do parents understand. Wil th fact that its experimental deter them or will they not like the idea of half the kids getting a placepo and not understand hat not saying yes will be worse.(the same).



To: Edward Paule who wrote (5351)1/17/1998 1:49:00 AM
From: aknahow  Read Replies (1) | Respond to of 17367
 
ED, mut reading IO is a post by Scott on the IDPH thread. Its 1433. If someone can cut and paste it over here it would be worth it. Deals with trial design and getting one product to market asap. Once there it will be used in the most appropriate way even if the trial was for some simpler more definable end point. Sorry, Scott, realize my explanation of your great post dose not do it justice.